
Therapeutic drug monitoring of TNF inhibitors
By R-BiopharmThe TAXIT study by KU Leuven demonstrated the positive effect of the therapeutic drug monitoring of infliximab with regards to cost savings and therapy optimisation....
Read more

Educating the global healthcare sector since 1998
The TAXIT study by KU Leuven demonstrated the positive effect of the therapeutic drug monitoring of infliximab with regards to cost savings and therapy optimisation....
Read more